Subhendu Nayak¹, Meghan McLean¹, Swetaleena Mishra² and Durga Madhab Swain³*

¹Vidya Herbs, 7 Otis Stone Hunter Road, Bunnell, Florida, USA
²Department of Biotechnology, Centurion University of Technology and Management, Bhubaneswar, Odisha, India
³MU Bond Life Sciences Center, University of Missouri, Columbia, USA

*Corresponding Author: Durga Madhab Swain, MU Bond Life Sciences Center, University of Missouri, Columbia, USA.

Received: April 23, 2024; Published: May 10, 2024

Abstract

A bacterium known as Akkermansia muciniphila (AkkermansiaA. muciniphila) was detected in human feces in 2004. It is defined as a gram-negative, anaerobic, and mucin-degrading microbe belonging to the Verrucomicrobia species. Although the majority of A. muciniphila is found in the human intestinal tract playing a role in the gut microbiome, there are also smaller levels detected in breast milk and oral cavities as well as in the pancreas and appendix. Evidence suggests that having A. muciniphila present in the gut microbiome has positive effects on human health. As a result, A. muciniphila has been shown to have health benefits when taken as a dietary supplementation where it is considered a promising next-generation probiotic. However, the large-scale production of A. muciniphila remains a challenge due to its need for a stable environment. While culturing A. muciniphila in a mucin-based medium is one option, other strategies that use plate-based mediums have also been explored. Currently, both live and pasteurized forms of A. muciniphila are available on the market and shown to have promising outcomes in animal models. Additionally, researchers are investigating various prebiotics to increase the abundance of A. muciniphila in the human gut. This article presents a detailed summary of the phenotypic characteristics of A. muciniphila and its associations with various human health condition illnesses. Finally, the paper explores A. muciniphila's potential as an effective next-generation probiotic.

Keywords: Akkermansia muciniphila; Gut Microbiome; Intestinal Mucin; Probiotic

References

1. Canakis A., et al. “Irritable bowel syndrome and gut microbiota”. Current Opinion in Endocrinology, Diabetes and Obesity 27 (2020): 28-35.
2. Lam YY., et al. “Are the Gut Bacteria Telling Us to Eat or Not to Eat? Reviewing the Role of Gut Microbiota in the Etiology, Disease Progression and Treatment of Eating Disorders”. Nutrients 6 (2017): 602.
3. Zitvogel L., et al. “Cancer and the gut microbiota: an unexpected link”. Science Translational Medicine271 (2015): 271ps1.
4. Gurung M., et al. “Role of gut microbiota in type 2 diabetes pathophysiology”. eBioMedicine 51 (2020): 102590.
5. Liang S., et al. “Gut-Brain Psychology: Rethinking Psychology from the Microbiota-Gut-Brain Axis”. Frontiers in Integrative Neuroscience 12 (2018): 33.
6. Rinninella E., et al. “What is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases”. Microorganisms1 (2019): 14.
7. Derrien M., et al. “Akkermansia muciniphila nov., sp. nov., a human intestinal mucin-degrading bacterium”. International Journal of Systematic and Evolutionary Microbiology 54 (2004): 1469-1476.
8. Collado MC., et al. “Intestinal integrity and Akkermansia muciniphila, a mucin-degrading member of the intestinal microbiota present in infants, adults, and the elderly”. Applied and Environmental Microbiology23 (2007): 7767-7770.
9. Derrien M., et al. “The Mucin degrader Akkermansia muciniphila is an abundant resident of the human intestinal tract”. Applied and Environmental Microbiology5 (2008): 1646-1648.
10. Plovier H., et al. “A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice”. Nature Medicine 23 (2017): 107-113.
11. Depommier C., et al. “Beneficial effects of akkermansia muciniphila are not associated with major changes in the circulating endocannabinoidome but linked to higher mono-Palmitoyl-Glycerol levels as new PPARα agonists”. Cells 10 (2021): 185.
12. Zhang T., et al. “Akkermansia muciniphila is a promising probiotic”. Microbial Biotechnology6 (2019): 1109-1125.
13. Ropot AV., et al. “Cultivation of the Next-Generation Probiotic Akkermansia muciniphila, Methods of Its Safe Delivery to the Intestine, and Factors Contributing to Its Growth In Vivo”. Current Microbiology 77 (2020): 1363-1372.
14. Reunanen J., et al. “Akkermansia muciniphila Adheres to Enterocytes and Strengthens the Integrity of the Epithelial Cell Layer”. Applied and Environmental Microbiology11 (2015): 3655-3662.
15. Brodmann T., et al. “Safety of Novel Microbes for Human Consumption: Practical Examples of Assessment in the European Union”. Frontiers in Microbiology 8 (2017): 1725.
16. Van der Hee B and Wells JM. “Microbial Regulation of Host Physiology by Short-chain Fatty Acids”. Trends in Microbiology 29 (2021): 700-712.
17. Ottman N., et al. “Action and function of Akkermansia muciniphila in microbiome ecology, health and disease”. Best Practice and Research. Clinical Gastroenterology6 (2017): 637-642.
18. Di Lorenzo A., et al. “Toll-Like Receptor 2 at the Crossroad between Cancer Cells, the Immune System, and the Microbiota”. International Journal of Molecular Sciences 21 (2020): 9418.
19. EFSA Panel on Nutrition. Novel Foods and Food Allergens (NDA) Turck D., et al. “Safety of asteurizedd Akkermansia muciniphila as a novel food pursuant to Regulation (EU) 2015/2283”. EFSA Journal 19 (2021): e06780.
20. Iwaza R., et al. “Akkermansia muciniphila: The state of the art, 18 years after its first discovery”. Frontiers in Gastroenterology (2022): 1.
21. Zhang H., et al. “Next-Generation Probiotics: Microflora Intervention to Human Diseases”. BioMed Research International (2022): 5633403.
22. Urbaniak C., et al. “Microbiota of human breast tissue”. Applied and Environmental Microbiology10 (2014): 3007-3014.
23. Aakko J., et al. “Human milk oligosaccharide categories define the microbiota composition in human colostrum”. Beneficial Microbes4 (2017): 563-567.
24. Kim SY and Yi DY. “Analysis of the human breast milk microbiome and bacterial extracellular vesicles in healthy mothers”. Experimental and Molecular Medicine 52 (2020): 1288-1297.
25. Štšepetova J., et al. “Maternal breast milk microbiota and immune markers in relation to subsequent development of celiac disease in offspring”. Scientific Reports 12 (2022): 6607.
26. Luna E., et al. “Utilization efficiency of human milk oligosaccharides by human-associated akkermansia is strain dependent”. Applied and Environmental Microbiology 88 (2022): e0148721.
27. Luan Z., et al. “Metagenomics Study Reveals Changes in Gut Microbiota in Centenarians: A Cohort Study of Hainan Centenarians”. Frontiers in Microbiology 11 (2020): 1474.
28. Shin J., et al. “Ageing and rejuvenation models reveal changes in key microbial communities associated with healthy ageing”. Microbiome 9 (2021): 240.
29. Cerro ED., et al. “Daily ingestion of Akkermansia mucciniphila for one month promotes healthy aging and increases lifespan in old female mice”. Biogerontology 23 (2022): 35-52.
30. Ma J., et al. “Gut microbiota remodeling improves natural aging-related disorders through Akkermansia muciniphila and its derived acetic acid”. Pharmacological Research 189 (2023): 106687.
31. Dhanjal DS., et al. “Plant Fortification of the Diet for Anti-Ageing Effects: A Review”. Nutrients 30 (2020): 12.
32. Zhou L., et al. “Curcumin Acetylsalicylate Extends the Lifespan of Caenorhabditis elegans”. Molecules 31 (2021): 26.
33. Boccardi V., et al. “Beta-carotene, telomerase activity and Alzheime’s disease in oldage subjects”. European Journal of Nutrition 59 (2020): 119-126.
34. Liu F., et al. “Apple polyphenols extract alleviated dextran sulfate sodium-induced ulcerative colitis in C57BL/6 male mice by restoring bile acid metabolism disorder and gut microbiota dysbiosis”. Phytotherapy Research 35 (2021): 1468-1485.
35. Santacruz A., et al. “Host remodeling of the gut microbiome and metabolic changes during pregnancy”. Cell3 (2012): 470-480.
36. Mesa MD., et al. “The Evolving Microbiome from Pregnancy to Early Infancy: A Comprehensive Review”. Nutrients1 (2020): 133.
37. Yoon HS., et al. “Akkermansia muciniphila secretes a glucagon-like peptide-1-inducing protein that improves glucose homeostasis and ameliorates metabolic disease in mice”. Nature Microbiology 6 (2021): 563-573.
38. Perraudeau F., et al. “Improvements to postprandial glucose control in subjects with type 2 diabetes: a multicenter, double blind, randomized placebo-controlled trial of a novel probiotic formulation”. BMJ Open Diabetes Research and Care1 (2020): e001319.
39. Abot A., et al. “Pasteurized Akkermansia muciniphila improves glucose metabolism is linked with increased hypothalamic nitric oxide release”. Heliyon7 (2023): e18196.
40. Druart C., et al. “Toxicological safety evaluation of pasteurized Akkermansia muciniphila”. Journal of Applied Toxicology 41 (2021): 276-290.
41. Grajeda-Iglesias C., et al. “Oral administration of akkermansia muciniphila elevates systemic antiaging and anticancer metabolites”. Aging 13 (2021): 6375-6405.
42. Salminen S., et al. “The international scientific association of probiotics and prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics”. Nature Reviews Gastroenterology and Hepatology 18 (2021): 649-667.
43. Ghaderi F., et al. “Effects of active, inactive, and derivatives of akkermansia muciniphila on the expression of the endocannabinoid system and PPARs genes”. Scientific Reports 12 (2022): 10031.
44. Yaghoubfar R., et al. “Effect of akkermansia muciniphila, faecalibacterium prausnitzii, and their extracellular vesicles on the serotonin system in intestinal epithelial cells”. Probiotics Antimicrob Proteins 13 (2021): 1546-56.
45. Si J., et al. “Revisiting the role of Akkermansia muciniphila as a therapeutic bacterium”. Gut Microbes 1 (2022): 2078619.
46. Leyrolle Q., et al. “Specific gut microbial, biological, and psychiatric profiling related to binge eating disorders: A cross-sectional study in obese patients”. Clinical nutrition (Edinburgh, Scotland)4 (2021): 2035-2044.

Citation

Citation: Durga Madhab Swain., et al. “Gut Microbiome’s Next Generation Probiotic: Akkermansia Overview and Supplementation Health Benefits".Acta Scientific Nutritional Health 8.6 (2024): 20-28.

Copyright

Copyright: © 2024 Durga Madhab Swain., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.